CRP and Thrombocytopenia: Elevated levels of inflammation markers, including interleukin 6 (IL-6), tumor necrosis factor α (TNF-α), C-reactive protein (CRP) and procalcitonin, were observed at 1–10 days or 11–20 days after symptom onset in the patients with thrombocytopenia (Fig. 4).